It is unclear whether newer molecules like semaglutide, which are larger and cause more weight loss than some of the earlier iterations, can cross the blood-brain barrier too
N Engl J Med 375:311322 Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
Diabetologia 57 , 13201324 (2014)
Tirzepatide (GLP-1 + GIP) supports appetite control and structured medical weight loss under physician supervision
The effects of semaglutide GLP-1 may begin to be noticeable within the first 1-2 weeks after the first shot
Barriers to alcohol use disorder treatment in patients with alcohol-associated liver disease